Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

RTTNews | 1148 วันที่ผ่านมา
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.

HT-TBI is being developed as a novel, point-of-care therapy for the treatment and/or prevention of secondary brain injury resulting from ischemic stroke and traumatic brain injury (TBI).

HT-TBI will be developed as a ready-to-use drug-device combination product for use in non-healthcare settings by patients and caregivers at risk for stroke/TBI, emergency healthcare professionals, and military personnel.

The HT-TBI formulation development and manufacturing work by Altasciences will be used to support a future Investigational New Drug (IND) Application to initiate clinical trials.

For More Such Health News, visit rttnews.com

แท็ก : HOTH
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 791 วันที่ผ่านมา
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews | 1048 วันที่ผ่านมา
European Shares Climb As US Senate Approves Deal To End Government Shutdown

European Shares Climb As US Senate Approves Deal To End Government Shutdown

European stocks hit a two-week high on Tuesday after the U.S. Senate passed a short-term funding bill to end the longest government shutdown in U.S, history. The bill will now be sent to the House, where a vote could come as early as Wednesday.
RTTNews | 1 ชม. 41 นาทีที่ผ่านมา
Asian Shares End On Mixed Note

Asian Shares End On Mixed Note

Asian stocks gave up early gains to end mixed on Tuesday after rising in the previous session as U.S. lawmakers moved toward reopening the federal government.
RTTNews | 2 ชม. 13 นาทีที่ผ่านมา
European Economic News Preview: UK Unemployment Data Due

European Economic News Preview: UK Unemployment Data Due

Unemployment from the UK and economic sentiment from Germany are the major economic reports due on Tuesday. At 2.00 am ET, the Office for National Statistics publishes UK labor market statistics. The jobless rate is forecast to rise to 4.9 percent in the three months to September from 4.8 percent in the preceding period.
RTTNews | 4 ชม. 7 นาทีที่ผ่านมา
Sensex, Nifty Modestly Lower In Cautious Trade

Sensex, Nifty Modestly Lower In Cautious Trade

Indian shares were a tad lower on Tuesday despite firm cues from global markets and comments from U.S. President Donald Trump that the U.S. was "pretty close" to a trade deal with New Delhi that's good for everybody.
RTTNews | 6 ชม. 27 นาทีที่ผ่านมา